Skip to content

Clinical trials

Phase 3 Atrophy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrophy Phase: Phase 3 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20065
20071
20081
20161
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shionogi5
Scholar Rock, Inc.2
University of Erlangen-Nürnberg Medical School2
National Cancer Center, Korea1
Oxagon1
Padagis LLC1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrophy13
Vaginal Diseases5
Muscular Atrophy2
Muscular Atrophy, Spinal2
Neuromuscular Diseases2
Neuromuscular Manifestations2
Spinal Muscular Atrophies of Childhood2
Atrophic Vaginitis1
Cardiovascular Diseases1
Diabetes Mellitus1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.